|
31.10.2014 |
EN |
Official Journal of the European Union |
C 386/1 |
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2014 to 31 July 2014
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))
2014/C 386/01
— Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
|
Date of the decision |
Name of the medicinal product |
INN (International Non-Proprietary Name) |
Holder of the marketing authorisation |
Number of the entry in the Community Register |
Pharmaceutical form |
ATC code (Anatomical Therapeutic Chemical Code) |
Date of notification |
|
18.7.2014 |
Simbrinza |
Brinzolamide/Brimonidine tartrate |
Alcon Laboratories (UK) Ltd Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom |
EU/1/14/933 |
Eye drops, suspension |
Pending |
23.7.2014 |